Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

17.6%

13 terminated/withdrawn out of 74 trials

Success Rate

78.7%

-7.8% vs industry average

Late-Stage Pipeline

45%

33 trials in Phase 3/4

Results Transparency

75%

36 of 48 completed trials have results

Key Signals

4 recruiting36 with results8 terminated5 withdrawn

Enrollment Performance

Analytics

Phase 4

23(41.8%)

Phase 3

10(18.2%)

Phase 2

8(14.5%)

Phase 1

7(12.7%)

N/A

6(10.9%)

Early Phase 1

1(1.8%)

55Total

Phase 4(23)

Phase 3(10)

Phase 2(8)

Phase 1(7)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (74)

Showing 20 of 74 trials

NCT06596616Enrolling By Invitation

Gadopiclenol vs Gadoxetate MRI for Liver Lesions

Role: collaborator

NCT06703450Enrolling By Invitation

Guerbet Liver Fibrosis

Role: collaborator

NCT03057561Not ApplicableCompleted

Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance

Role: collaborator

NCT05954559Phase 4Recruiting

High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment

Role: collaborator

NCT03727633Phase 2Terminated

Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion

Role: collaborator

NCT07083115Enrolling By Invitation

Developing MRI Technologies for Atrial Fibrillation

Role: collaborator

NCT03730051Phase 4Completed

Dotarem vs Gadobutrol Contrast for Breast MRI

Role: collaborator

NCT06057168Phase 3Completed

Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas

Role: lead

NCT04373564Phase 4Recruiting

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Role: lead

NCT07348640Phase 3Not Yet Recruiting

Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease

Role: lead

NCT05590884Phase 2Completed

Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age

Role: lead

NCT03986138Phase 3Completed

Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)

Role: lead

NCT06226129Phase 4Recruiting

Gadopiclenol in Contrast Enhanced MRI of the Prostate

Role: collaborator

NCT02625389Phase 4Completed

A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures